Highest infection as tests hit new high of 2.42 lakh

New Delhi

A record number of 20,903 persons were found infected with the Covid-19 virus in a day on Friday even as 2,41,576 persons underwent testing to raise the total persons checked so far to 92.98 lakh.

So far, 6.47 lakh persons have been tested with the positive symptoms, while 2.37 lakh of them are still under treatment in the hospitals across the country while 3,93,869 have been cured and discharged from the hospitals, over 20,000 in the past 24 hours. The lowest 432 were hospitalised since Thursday.

The death toll in the country rose to 18,213, with as many as 479 succumbing to the dreaded virus in the past 24 hours.

Virus update

Total cases: 6,47,524

Active cases: 2,37,333

Recovered: 3,93,869

New cases

Gujarat: 687

Tamil Nadu: 4,329

Delhi: 2,520

Rajasthan: 390

Madhya Pradesh: 191

Uttar Pradesh: 972

West Bengal: 669

Haryana: 494

Karnataka: 1,694

Telangana: 1,103

J&K: 170

Bihar: 229

Andhra Pradesh: 837

Total cases: (Friday 21,556 vs 21,110 Thursday) Recovered: 13,900

Deaths: 452

—Firstsquawk covid Tracker

Zydus vaccine gets DCGI nod for human clinical trial

Zydus vaccine for COVID-19 (ZyCoV-D) has successfully completed pre-clinical development and received permission to initiate human clinical trials. The vaccine is found to be immunogenic in multiple animal species. Antibodies produced in animal studies are able to completely neutralize the wild type virus, a firm statement said.

Preclinical toxicity studies find the vaccine to be well tolerated, safe and immunogenic and the company plans to start the human clinical trials in July 2020.

Delhi’s Lok Nayak Hosp discontinues use of Favipiravir

Amid the ongoing debate over benefits and side-effects of using the antiviral medication Favipiravir, Delhi government-run Lok Nayak Hospital – the national capital’s first COVID-19 only facility – has decided to discontinue the drug among its patients. The decision was taken in a meeting called the director professor of medicine Dr MK Daga of the hospital on June 29. The drug was being given in mild to moderate cases. However, doctors decided to discontinue its use because of the side-effects. Favipiravir is an oral antiviral drug approved in Japan in 2014 for the treatment of novel or re-emerging influenza virus infections. It has a unique me­ch­anism of action by whi­ch it inhibits viral replication or reproduction.

(To view our epaper please click here. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Free Press Journal